<DOC>
	<DOCNO>NCT01428102</DOCNO>
	<brief_summary>During normal physiological condition hemostasis ( ability blood clot ) keep homeostatic balance feedback mechanism . These mechanism involve extremely complex series step side coagulation cascade include cellular component ( i.e . clot formation breakdown ) . However , homeostatic balance upset , normal hemostasis affect result pathological clotting ( vessel blockage ) bleeding ( hemorrhage ) . In instance include acquire congenital abnormality hemostatic system clinically important diagnose , monitor manage patient optimize therapeutic intervention . Moreover , important regulate hemostasis system post-surgical outpatient receive oral anticoagulant therapy maintain homeostatic balance . The TEG® analyzer , use small whole blood sample , document interaction platelet protein coagulation cascade time place blood analyzer initial fibrin formation , clot rate strengthen fibrin-platelet bonding via GPIIb/IIIa , eventual clot lysis . It display qualitatively quantitatively two distinct part hemostasis - part produce clot part cause breakdown clot . It show balance degree imbalance patient 's hemostasis system , highlight area deficiency excess , offer precise view patient 's hemostasis condition . If system balance , one see imbalance lie . If patient bleeding , crucial determine cause bleed soon possible order start proper treatment . By utilize kaolin/tissue factor activator ( RapidTEG™ ) , TEG® system measure interaction simultaneous contribution intrinsic extrinsic coagulation pathway initiate result clot formation . This RapidTEG™ reagent deliver result faster activate Kaolin alone . This protocol specifically assess one algorithm call MA . MA direct function maximum dynamic property fibrin platelet bonding via GPIIb/IIIa represent ultimate strength fibrin clot . This represent platelet function . The objective study demonstrate substantial equivalence MA RapidTEG vs. MA Kaolin .</brief_summary>
	<brief_title>RapidTEG MA Validation</brief_title>
	<detailed_description />
	<mesh_term>Kaolin</mesh_term>
	<criteria>Patient age &gt; 18 year old Patient either Trauma patient OR diagnose know cardiovascular disease . Samples must test within recommended timeline ( 46 minute noncitrated 15 minute 2 hour citrate ) Patients place anticoagulation prophylaxis condition ( CPB/PCI relate ) . Patients establish hemostasis system abnormality ( congenital ) . Samples identify affected testing error lab staff .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>Thromboelastography</keyword>
	<keyword>TEG</keyword>
	<keyword>Coagulation</keyword>
	<keyword>RapidTEG</keyword>
	<keyword>Kaolin</keyword>
</DOC>